Glioma Developmental and HyperActive Ras Tumor (DHART) Board
Part of paid clinical trials in Basking Ridge, New Jersey.
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study ID
- NCT05489783
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
This study will collect medical records, scan results, and complete surveys to create a registry about people with a neurofibromatosis type 1-associated brain tumor (NF1-associated glioma). A registry is a collection of health information about individuals, and it is usually focused on a specific diagnosis or condition. This registry study will help the researchers learn more about the diagnosis, treatment, and quality of life of people with NF1-associated glioma. The researchers want to understand what happens as a result of different treatments for NF1-associated glioma and how these treatments and the disease itself affect people's lives over a period of time. Information collected during this study could affect how doctors diagnose, test, and treat NF1-associated glioma, and the study could help future patients with this type of cancer.
Key Dates
- Start date
- Jul 29, 2022
- Status verified
- Jun 2025
- Primary completion
- Jul 31, 2026
- Completion
- Jul 31, 2026
Study Design
- Enrollment
- 50 participants (estimated)
Primary Outcome Measure
Registry of patients with Neurofibromatosis Type 1 (NF1) associated glioma [ Time Frame: 5 years ]
Central Contacts
- Anna Piotrowski, MD212-610-0483
- Ingo Mellinghoff, MD646-888-3036
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Memorial Sloan Kettering Basking Ridge (All Protocol Activities) | Basking Ridge | New Jersey | 07920 | Anna Piotrowski, MD 212-610-0483 |
| Memorial Sloan Kettering Monmouth (All protocol activities) | Middletown | New Jersey | 07748 | Anna Piotrowski, MD 212-610-0483 |
| Memorial Sloan Kettering Bergen (All Protocol Activities) | Montvale | New Jersey | 07645 | Anna Piotrowski, MD 212-610-0483 |
| Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities) | Commack | New York | 11725 | Anna Piotrowski, MD 212-610-0483 |
| Memorial Sloan Kettering West Harrison (All Protocol Activities) | Harrison | New York | 10604 | Anna Piotrowski, MD 212-610-0483 |
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) | New York | New York | 10065 | Anna Piotrowski, MD 212-610-0483 Ingo Mellinghoff, MD 646-888-3036 |
| Memorial Sloan Kettering Nassau (All Protocol Activities) | Rockville Centre | New York | 11570 | Anna Piotrowski, MD 212-610-0483 |
Find similar trials in Basking Ridge, NJ
Related Studies
- Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid TumorsRecruiting · Memorial Sloan Kettering Cancer Center · New York, New York
- Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)PHASE1/PHASE2 · Recruiting · Plus Therapeutics · Manhasset, New York
- Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOAPHASE2 · Recruiting · Northwell Health · New York, New York
- Telehealth Visits to Discuss Advanced Directives for Patients Newly Diagnosed With High Grade GliomaRecruiting · University of Rochester · Rochester, New York